Cargando…
P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430921/ http://dx.doi.org/10.1097/01.HS9.0000970376.71405.63 |
_version_ | 1785091075568828416 |
---|---|
author | Bahlis, Nizar J Trudel, Suzanne Quach, Hang Popat, Rakesh Lonial, Sagar Orlowski, Robert Z Kim, Kihyun Mateos, Maria-Victoria Pawlyn, Charlotte Ramasamy, Karthik Martinez-Lopez, Joaquín Casas-Avilés, Ignacio Spirli, Alessia Gong, Jing Amatangelo, Michael Katz, Jessica Maciag, Paulo Peluso, Teresa Richardson, Paul |
author_facet | Bahlis, Nizar J Trudel, Suzanne Quach, Hang Popat, Rakesh Lonial, Sagar Orlowski, Robert Z Kim, Kihyun Mateos, Maria-Victoria Pawlyn, Charlotte Ramasamy, Karthik Martinez-Lopez, Joaquín Casas-Avilés, Ignacio Spirli, Alessia Gong, Jing Amatangelo, Michael Katz, Jessica Maciag, Paulo Peluso, Teresa Richardson, Paul |
author_sort | Bahlis, Nizar J |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104309212023-08-17 P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL Bahlis, Nizar J Trudel, Suzanne Quach, Hang Popat, Rakesh Lonial, Sagar Orlowski, Robert Z Kim, Kihyun Mateos, Maria-Victoria Pawlyn, Charlotte Ramasamy, Karthik Martinez-Lopez, Joaquín Casas-Avilés, Ignacio Spirli, Alessia Gong, Jing Amatangelo, Michael Katz, Jessica Maciag, Paulo Peluso, Teresa Richardson, Paul Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430921/ http://dx.doi.org/10.1097/01.HS9.0000970376.71405.63 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Bahlis, Nizar J Trudel, Suzanne Quach, Hang Popat, Rakesh Lonial, Sagar Orlowski, Robert Z Kim, Kihyun Mateos, Maria-Victoria Pawlyn, Charlotte Ramasamy, Karthik Martinez-Lopez, Joaquín Casas-Avilés, Ignacio Spirli, Alessia Gong, Jing Amatangelo, Michael Katz, Jessica Maciag, Paulo Peluso, Teresa Richardson, Paul P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL |
title | P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL |
title_full | P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL |
title_fullStr | P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL |
title_full_unstemmed | P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL |
title_short | P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL |
title_sort | p868: mezigdomide (mezi) plus dexamethasone (dex) in patients (pts) with relapsed/refractory multiple myeloma (rrmm): results from the dose-expansion phase of the cc-92480-mm-001 trial |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430921/ http://dx.doi.org/10.1097/01.HS9.0000970376.71405.63 |
work_keys_str_mv | AT bahlisnizarj p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT trudelsuzanne p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT quachhang p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT popatrakesh p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT lonialsagar p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT orlowskirobertz p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT kimkihyun p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT mateosmariavictoria p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT pawlyncharlotte p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT ramasamykarthik p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT martinezlopezjoaquin p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT casasavilesignacio p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT spirlialessia p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT gongjing p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT amatangelomichael p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT katzjessica p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT maciagpaulo p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT pelusoteresa p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial AT richardsonpaul p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial |